DR. REDDY S LABORATORIES
Stock Price Chart
DR. REDDY S LABORATORIES
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Key Valuation & Ratios
SWOT Analysis
- Strong ROCE (10.8%)
- Sound financial health
- Market leader position
- Valuation multiplier (35.1x)
- Susceptible to macro headwinds
- Expanding sector trends
- Operational automation
- Stiff domestic competition
- Regulatory policy changes
Pros & Cons
- Consistent return ratios
- Stable business snapshot
- Strong promoter support
- Premium P/E over sector median
- Raw material input inflation
SEBI Filings & Corporate Announcements
Official BSE/NSE disclosures and announcements in chronological order